Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
A randomized controlled trial of dapagliflozin plus once-weekly exenatide versus placebo in individuals with obesity and without diabetes: metabolic effects and markers associated with bodyweight loss
Jen : So good
Judge Karen Marston issued a July 2 case management order directing early discovery in the Ozempic and Wegovy NAION litigation to focus first on cross-cutting issues: whether plaintiffs can establish general causation between GLP-1 drugs and vision loss, and whether federal law preempts failure-to-warn claims
43 Notably, patients receiving liraglutide were reported to have a numerically higher risk of the composite outcome of death and HF hospitalisation overall, although this was not statistically significant (HR 1.30
US$ 26.06
US$ 25.80
US$ 21.50
US$ 20.15
US$ 22.88
